The latest call
FetchingHims & Hers Health, Inc. reported on November 9, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
HIMS · NYSE · Healthcare · Drug Manufacturers Specialty and Generic
$19.730.0%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 9, 2026
Hims & Hers sells prescription treatments and non-prescription health products to consumers, mainly through online subscriptions paired with remote consultations from licensed clinicians.
Company outlook: revenue of $875M to $895M for Fiscal Q4 2026 — up 43.2% on a year earlier
Just reported
From Hims & Hers Health, Inc.'s results release of November 9, 2026; its quarterly report has since been filed.
Actual
$890.4M
+49% y/y
+18% q/q
Guided
$890M
midpoint
Actual
-$0.14
Guided
—
No guide given
| Measure | 3 months toSep 30, 2026 | 3 months toSep 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $890.4M | $599M | +48.65% |
| Profit | -$33M | $15.8M | -309.46% |
| Profit per share | -$0.14 | $0.06 | -333.33% |
| Free Cash Flow | $26M | $79.4M | -67.27% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Hims & Hers Health, Inc. reported on November 9, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
“In healthcare, whoever owns the customer relationship wins, and that’s exactly what we’re building toward at Hims & Hers. Today, customers want real choice, real value, and a care team that knows them,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.
Hims & Hers is the leading global health and wellness platform on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the Company provides access to personalized care designed for results.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Hims & Hers Health, Inc.’s Item 2.02 8-K filed November 9, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Actual
-$66.1M
Guided
—
No guide given
Q4 2026
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.